Wikidata

(Q62105998)

English

Study of DOXIL/CAELYX (Pegylated Liposomal Doxorubicin) and VELCADE (Bortezomib) or VELCADE Monotherapy for the Treatment of Relapsed Multiple Myeloma

clinical trial

In more languages

Statements

title
A Randomized Controlled Study of DOXIL/CAELYX (Doxorubicin HCL Liposome Injection) and VELCADE (Bortezomib) or VELCADE Monotherapy for the Treatment of Relapsed Multiple Myeloma (English)
0 references
country
Argentina
0 references
Australia
0 references
Austria
0 references
Belgium
0 references
Canada
0 references
Czech Republic
0 references
France
0 references
Israel
0 references
Netherlands
0 references
Poland
0 references
Portugal
0 references
Singapore
0 references
South Africa
0 references
Spain
0 references
United Kingdom
0 references
start time
December 2004
0 references
end time
May 2014
0 references
number of participants
646
0 references
research intervention
doxorubicin
0 references
Caelyx
0 references
bortezomib
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q62105998&oldid=1857055772"